Affini-T

Series-A
affinittx.com Biotech & Healthcare Watertown, United States Founded 2021 51–100 employees
Total Funding $175M
Latest Round $175M Series-A
Last Announced Mar 22, 2022
Investors 10 Backers
Decision Makers 6 Available

About Affini-T

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Watertown, United States
Year Founded 2021
Team Size 51–100 employees
Tracked Since Nov 16, 2026

Web & Domain Identity

Official Website affinittx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @affinit_tx (243 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $175,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Company founded

    Watertown, United States

Investors & Backers

10
Agent Capital
Alexandria Venture Investments
Catalio
Erasca Ventures
Fred Hutchinson
Humboldt Fund
Jacket River
Leaps by Bayer
Parker Institute for Cancer Immunotherapy
Vida Ventures

Funding History

1 Round
Series-A equity · Mar 22, 2022

Founders & Leadership

5

Arjun Goyal

Founder

Work email & phone locked Unlock →

Jak Knowles

Founder

Work email & phone locked Unlock →

Kathy Yi

Chief Operating Officer

Work email & phone locked Unlock →

Kim Nguyen

Chief Technical Officer

Work email & phone locked Unlock →

Loic Vincent

CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts